Back to Search
Start Over
Cefazolin-Induced Thrombocytopenia in a Patient with Polycythemia Vera Following Coronary Artery Bypass.
- Source :
-
Seminars in cardiothoracic and vascular anesthesia [Semin Cardiothorac Vasc Anesth] 2022 Mar; Vol. 26 (1), pp. 83-85. Date of Electronic Publication: 2021 Dec 29. - Publication Year :
- 2022
-
Abstract
- Cefazolin is an antibiotic that is commonly administered perioperatively to reduce the risk of surgical site infections. Cephalosporins have a well-established safety profile, but have been associated with thrombocytopenia and neutropenia due to their myelosuppressive effects. While this effect may be benign in healthy patients undergoing minor surgery, it can be detrimental in patients with underlying hematologic disorders presenting for open-heart surgery. Herein, we discuss the first case in the literature of cefazolin-induced thrombocytopenia and severe coagulopathy in a patient with polycythemia vera (PCV) during a coronary artery bypass-grafting surgery.
- Subjects :
- Cefazolin adverse effects
Coronary Artery Bypass adverse effects
Humans
Surgical Wound Infection chemically induced
Surgical Wound Infection complications
Polycythemia Vera chemically induced
Polycythemia Vera complications
Polycythemia Vera drug therapy
Thrombocytopenia chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1940-5596
- Volume :
- 26
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Seminars in cardiothoracic and vascular anesthesia
- Publication Type :
- Academic Journal
- Accession number :
- 34965170
- Full Text :
- https://doi.org/10.1177/10892532211065234